Announce Date | 02/25/2025 |
EPS Normalized Actual | $0.79 (Beat by $0.08) |
EPS GAAP Actual | $0.79 (Beat by $0.08) |
Revenue Actual | $1.9595B |
Revenue Surprise | Beat by $1959.5M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.95982 |
EPS GAAP Estimate | $0.95982 |
Revenue Estimate | $1.165967083B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 4.49576 | 19.42 | 4.38269 | 4.71531 | 2 |
Dec 2026 | 5.08 | 17.19 | 4.95937 | 5.22066 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.86 | 0.14981 | 1.9595B | 17.89% | 562.17M |
FQ3 2024 (Sep 2024) | 0.9 | 0.9 | 1.9294B | 12.24% | 1929.4M |
FQ2 2024 (Jun 2024) | 0.74 | 0.74 | 1.8897B | 13.31% | 1889.7M |
FQ1 2024 (Mar 2024) | 0.7 | 0.7 | 1.7214B | 10.58% | 1721.4M |
FQ4 2023 (Dec 2023) | 0.66 | 0.66 | 1.609B | 5.94% | 1609M |
FQ3 2023 (Sep 2023) | 0.94 | 0.94 | 1.6932B | 12.99% | 1693.2M |
FQ2 2023 (Jun 2023) | 0.79 | 0.79 | 1.6382B | 15.97% | 1638.2M |
FQ1 2023 (Mar 2023) | 0.59 | 0.59 | 1.5392B | 100% | 1539.2M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.95982
Consensus Revenue Estimates
1.165967083B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.2911 | -- | 1.21328 | 1.3507 | 2 |
FQ2 2027 (Jun 2027) | 1.19721 | -- | 1.12505 | 1.25248 | 2 |
FQ1 2027 (Mar 2027) | 0.95167 | -- | 0.89431 | 0.9956 | 2 |
FQ4 2026 (Dec 2026) | 0.9117 | -- | 0.9117 | 0.9117 | 2 |
FQ3 2026 (Sep 2026) | 1.22037 | -- | 1.22037 | 1.22037 | 2 |
FQ2 2026 (Jun 2026) | 1.112 | -- | 1.112 | 1.112 | 2 |
FQ1 2026 (Mar 2026) | 0.87462 | -- | 0.87462 | 0.87462 | 2 |
FQ4 2025 (Oct 2025) | 1.07438 | 19.95 | 1.04579 | 1.10008 | 2 |
FQ3 2025 (Jul 2025) | 0.95342 | 5.6 | 0.92805 | 0.97623 | 2 |
FQ2 2025 (Jun 2025) | 0.95982 | 22.9 | 0.93744 | 0.98494 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.85B | -- | 1.76B | 1.92B | 2 |
FQ2 2027 (Jun 2027) | 1.83B | -- | 1.75B | 1.9B | 2 |
FQ1 2027 (Mar 2027) | 1.76B | -- | 1.68B | 1.83B | 2 |
FQ4 2026 (Dec 2026) | 1.53B | -- | 1.53B | 1.53B | 4 |
FQ3 2026 (Sep 2026) | 1.78B | -- | 1.78B | 1.78B | 4 |
FQ2 2026 (Jun 2026) | 1.74B | -- | 1.74B | 1.74B | 4 |
FQ1 2026 (Mar 2026) | 1.57B | -- | 1.57B | 1.57B | 4 |
FQ4 2025 (Oct 2025) | 1.62B | -21.19 | 1.58B | 1.65B | 1 |
FQ3 2025 (Jul 2025) | 1.57B | -22.88 | 1.54B | 1.6B | 1 |
FQ2 2025 (Jun 2025) | 1.17B | -62.07 | 1.15B | 1.19B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.71019 | 0.86 | 0.14981 | 17.42% |
FQ3 2024 (Sep 2024) | 0.9 | 0.9 | 100% | |
FQ2 2024 (Jun 2024) | 0.74 | 0.74 | 100% | |
FQ1 2024 (Mar 2024) | 0.7 | 0.7 | 100% | |
FQ4 2023 (Dec 2023) | 0.66 | 0.66 | 100% | |
FQ3 2023 (Sep 2023) | 0.94 | 0.94 | 100% | |
FQ2 2023 (Jun 2023) | 0.79 | 0.79 | 100% | |
FQ1 2023 (Mar 2023) | 0.59 | 0.59 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $1.4B | $1.96B | $562.17M | 28.69% |
FQ3 2024 (Sep 2024) | $0B | $1.93B | $1929.4M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.89B | $1889.7M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.72B | $1721.4M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.61B | $1609M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.69B | $1693.2M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.64B | $1638.2M | 100% |
FQ1 2023 (Mar 2023) | $0B | $1.54B | $1539.2M | 100% |